Logo image of QNTM

QUANTUM BIOPHARMA LTD (QNTM) Stock Price, Quote, News and Overview

NASDAQ:QNTM - Nasdaq - CA74764Y2050 - Common Stock - Currency: USD

4.62  +0.12 (+2.67%)

QNTM Quote, Performance and Key Statistics

QUANTUM BIOPHARMA LTD

NASDAQ:QNTM (3/7/2025, 8:00:01 PM)

4.62

+0.12 (+2.67%)

Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
Statistics
52 Week HighN/A
52 Week LowN/A
Market Cap10.63M
Shares2.30M
Float2.04M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)03-26 2025-03-26
IPO05-29 2018-05-29


QNTM short term performance overview.The bars show the price performance of QNTM in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -20 -40 -60

QNTM long term performance overview.The bars show the price performance of QNTM in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of QNTM is 4.62 USD. In the past month the price decreased by -68.14%.

QUANTUM BIOPHARMA LTD / QNTM Daily stock chart

QNTM Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 66.89 824.51B
JNJ JOHNSON & JOHNSON 16.69 401.33B
NVO NOVO-NORDISK A/S-SPONS ADR 26.18 386.95B
AZN ASTRAZENECA PLC-SPONS ADR 21.41 240.28B
MRK MERCK & CO. INC. 12.39 239.09B
NVS NOVARTIS AG-SPONSORED ADR 14.56 228.26B
PFE PFIZER INC 8.59 151.49B
SNY SANOFI-ADR 14.24 148.55B
BMY BRISTOL-MYERS SQUIBB CO 53.59 123.97B
GSK GSK PLC-SPON ADR 8.29 81.62B
ZTS ZOETIS INC 28.78 76.29B
TAK TAKEDA PHARMACEUTIC-SP ADR 33.71 47.88B

About QNTM

Company Profile

QNTM logo image Quantum BioPharma Ltd is a CA-based company operating in Pharmaceuticals industry. The company is headquartered in Toronto, Ontario. The company went IPO on 2018-05-29. Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The firm is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. The company maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.

Company Info

QUANTUM BIOPHARMA LTD

First Canadian Place, 100 King Street West, Suite 4000

TORONTO ONTARIO CA

Employees: 10

Company Website: https://www.fsdpharma.com/

Investor Relations: http://www.fsdpharma.com/investors

Phone: 14168548884

QUANTUM BIOPHARMA LTD / QNTM FAQ

What is the stock price of QUANTUM BIOPHARMA LTD today?

The current stock price of QNTM is 4.62 USD. The price increased by 2.67% in the last trading session.


What is the ticker symbol for QUANTUM BIOPHARMA LTD stock?

The exchange symbol of QUANTUM BIOPHARMA LTD is QNTM and it is listed on the Nasdaq exchange.


On which exchange is QNTM stock listed?

QNTM stock is listed on the Nasdaq exchange.


What is QUANTUM BIOPHARMA LTD worth?

QUANTUM BIOPHARMA LTD (QNTM) has a market capitalization of 10.63M USD. This makes QNTM a Nano Cap stock.


How many employees does QUANTUM BIOPHARMA LTD have?

QUANTUM BIOPHARMA LTD (QNTM) currently has 10 employees.


What are the support and resistance levels for QUANTUM BIOPHARMA LTD (QNTM) stock?

QUANTUM BIOPHARMA LTD (QNTM) has a support level at 4.38 and a resistance level at 4.9. Check the full technical report for a detailed analysis of QNTM support and resistance levels.


Should I buy QUANTUM BIOPHARMA LTD (QNTM) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does QUANTUM BIOPHARMA LTD (QNTM) stock pay dividends?

QNTM does not pay a dividend.


When does QUANTUM BIOPHARMA LTD (QNTM) report earnings?

QUANTUM BIOPHARMA LTD (QNTM) will report earnings on 2025-03-26.


What is the Short Interest ratio of QUANTUM BIOPHARMA LTD (QNTM) stock?

The outstanding short interest for QUANTUM BIOPHARMA LTD (QNTM) is 16.1% of its float. Check the ownership tab for more information on the QNTM short interest.


QNTM Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to QNTM.


Chartmill TA Rating
Chartmill Setup Rating

QNTM Financial Highlights


Industry RankSector Rank
PM (TTM) N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)N/A
Revenue 1Y (TTM)N/A

QNTM Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 83% to QNTM. The Buy consensus is the average rating of analysts ratings from 7 analysts.


Ownership
Inst Owners14.84%
Ins Owners10.5%
Short Float %16.1%
Short Ratio0.11
Analysts
Analysts82.86
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A